Veterinary Medicine Information website

CEFOKEL 50 mg/ml, suspension for injection for pigs and cattle

Not authorised
  • Ceftiofur hydrochloride
Download as PDF

Product identification

Medicine name:
CEFOKEL 50 mg/ml, suspension for injection for pigs and cattle
Active substance:
  • Ceftiofur hydrochloride
Target species:
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ceftiofur hydrochloride
    53.48
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Spain
Package description:
  • Colourless glass type I vial of 100 ml, closed with grey coated bromobutyl rubber stoppers and aluminium caps.Vials are individually packed in a carton box.Twelve vials are grouped as a clinical pack.
  • Colourless glass type I vial of 100 ml, closed with grey coated bromobutyl rubber stoppers and aluminium caps.Vials are individually packed in a carton box.Ten vials are grouped as a clinical pack.
  • Colourless glass type I vial of 100 ml, closed with grey coated bromobutyl rubber stoppers and aluminium caps.Vials are individually packed in a carton box.Six vials are grouped as a clinical pack.
  • Colourless glass type I vial of 100 ml, closed with grey coated bromobutyl rubber stopper and aluminium cap.Vial is individually packed in a carton box.One vial is grouped as a clinical pack.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2784 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0303/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/09/2025
Download

Combined File of all Documents

English (PDF)
Published on: 28/09/2025
Download